Tune Therapeutics
Developer of an epigenetic programming platform designed to create new pathways for the treatment of disease. The company's platform helps to develop paradigm-changing cell and gene therapies that lev...
Valuation
$340M
Market implied
Share Price
N/A
Total Raised
$222.4M
Last Round
N/A